Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 15, 2006

View Archived Issues

KKJA-0036: novel T-type calcium channel blocker is effective against visceral pain

Medicure looks back on fiscal 2006

CRTH2 receptor identified as a novel therapeutic target for chronic allergic skin inflammation

Spotlight on aspirin: Novel non-COX-1-mediated pathways involved in antithrombotic effects

Preliminary results from phase III study of CIP-Tramadol ER

Enrollment under way in phase IIa safety study of NTx-265 in stroke

Tripos and CeNeS extend COMT inhibitor research agreement

Plans for primate study of BrainStorm's Parkinson's disease stem cell therapy

SIGA receives grant to support Lassa fever virus antiviral program

Curis establishes Chinese presence, updates key program progress

VQD-002 studied for leukemia in new phase I/II trial

Higher doses of Viramidine to be examined following phase III findings

OrCel superior to standard of care in healing difficult to heal venous leg ulcers

BioLineRx inlicenses BL-3030 for inflammatory diseases

Sugars from avocado enhance cutaneous defense mechanisms

TB4 significantly improves cardiac function following heart attack in animal study

Discovery Partners International stockholders approve Infinity merger

Recent patents describe new agents for endocrine-related disorders

New therapeutic agents for urological disorders imparted in recent patents

Compounds with potential use in neurological disorders disclosed

Good oral bioavailability and safety profile for new oxytocin antagonist

Component of brown seaweed shows antiobesity properties

Argenta Discovery reports on novel histone deacetylase inhibitors

Potentially new antiinflammatory drugs targeting mPGES-1 presented by Merck

Romidepsin studied in combination with gemcitabine in new trial

Radius and Karo Bio announce licensing agreement for novel SARMs

Preclinical testing for Advanced Refractive Technologies' novel glaucoma treatment

ADA/EASD consensus recommends metformin at diagnosis of type 2 diabetes

Invirase 500 mg launched in Japan

Valtrex approved in Japan to prevent recurrence of genital herpes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...